Health CEOs made $4 billion in 2022; new definition of a human embryo proposed

The combined health care CEO compensation could buy Costco memberships for more than 66 million people.

August 17, 2023 Check out STAT+

Sponsored By

Mike Reddy for STAT STAT+ | Health care CEOs hauled in $4 billion last year as inflation pinched workers, analysis shows The CEOs of more than 300 publicly traded health care companies combined to make $4 billion in 2022, according to a STAT analysis. By Bob Herman and J. Emory Parker and Adam Feuerstein and Lizzy Lawrence and Mohana Ravindranath STAT+ | U.S. appeals court strikes down key provisions in Oklahoma law that regulates PBMs A U.S. appeals court struck down key parts of an Oklahoma law designed to regulate the retail networks created by pharmacy benefit managers. By Ed Silverman STAT+ | Blue Shield of California overhauls drug pricing operation — by adding more vendors Blue Shield of California is restructuring how it will pay for prescription drugs by dividing the work up among five different vendors. By Bob Herman Christopher Furlong/Getty Images New definition of a human embryo proposed amid rapid scientific advances Scientists proposed that human embryos be defined not by how they were made, but by their "potential to form a fetus." By Megan Molteni STAT+ | South Africa ordered to disclose contracts with Pfizer, J&J, and other Covid-19 vaccine suppliers "This is a victory for democracy," said Fatima Hassan, who founded Health Justice Initiative, an advocacy group that sued the government. By Ed Silverman STAT+ | ActiGraph executives on why getting digital endpoints approved for drug trials matters ActiGraph executives spoke with STAT about getting a drug approved with a digital endpoint in a clinical trial using wearables. By Mario Aguilar Adobe Opinion: The definition of clinical trial diversity must include disabled people Despite constituting the largest minority group in the U.S., people with disabilities remain heavily excluded from the process. By Liz Beatty

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser